BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.130
-0.030 (-2.59%)
At close: Oct 15, 2026, 4:00 PM EDT
1.120
-0.010 (-0.88%)
After-hours: Oct 15, 2026, 7:20 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $8.52 million as of October 15, 2026. It is the 42,435th most valuable company in the world and the 5,712th biggest in the United States. Its market cap has decreased by 43.56% in one year.
Market Cap
8.52M
Enterprise Value
-178.76K
1-Year Change
-43.56%
Global Rank
Country Rank
#5,712 United States
Category
ChartMarket Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $8.52M, a decrease of -83.61%. That is a compound annual growth rate of -25.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 8.52M | -2.03% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 10.71M |
| Chemomab Therapeutics | 10.07M |
| Theriva Biologics | 10.07M |
| Vistagen Therapeutics | 10.06M |
| Senti Biosciences Holdings | 9.92M |
| CytoMed Therapeutics | 9.68M |
| MetaVia | 9.55M |
| Lisata Therapeutics | 9.46M |